Search Results - Dolezal, M.V

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1205 A first-in-human Phase I study to evaluate the pan-PI3K inhibitor GDC-0941 administered QD or BID in patients with advanced solid tumours

    1205 A first-in-human Phase I study to evaluate the pan-PI3K inhibitor GDC-0941 administered QD or BID in patients with advanced solid tumours by Von Hoff, D.D, Wagner, A.J, LoRusso, P.M, Tibes, R, Jin, J, Ware, J.A, Yan, Y, Derynck, M.K, Dolezal, M.V, Demetri, G.D

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    1204 A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941

    1204 A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941 by Kristeleit, R, Sarker, D, Forster, M, Lolkema, M, Olmos, D, Mazina, K, Dolezal, M.V, Ware, J.A, Yan, Y, de Bono, J.S

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: